Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus

doi:10.1084/jem.155.5.1427

This Article

Full Text (PDF, 940K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Iida, K.

Articles by Nussenzweig, V.

Search for Related Content

PubMed

PubMed Citation

Articles by Iida, K.

Articles by Nussenzweig, V.

Pubmed/NCBI databases

Medline Plus Health Information
Gene	GEO Profiles
HomoloGene	OMIM
UniGene
Substance via MeSH
Lupus

Social Bookmarking

What's this?

ARTICLES

Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus

K Iida, R Mornaghi and V Nussenzweig

This study reports quantitative information on the concentration of complement receptor for C3b and C4b (CR1) on erythrocytes from normal individuals and patients with immune complex disease. The measurements were performed by an immunoradiometric assay using monoclonal antibodies against CR1. The antibody specificity was confirmed by immunoprecipitation of CR1 from extracts of surface-labeled cells, by inhibition of rosette formation between B lymphocytes and the erythrocytes intermediate EAC14oxy23b, and by the characteristic distribution of the antigen among cells of human peripheral blood. The number of CR1 molecules in erythrocytes from 52 normal individuals was estimated as 1,410 +/- 620. No significant differences in CR1 levels were observed when individuals were grouped by sex, age, or blood groups. In patients with SLE and rheumatoid arthritis, the number of CR1 molecules per RBC was significantly lower, i.e., 600 +/- 307 and 903 +/- 417, respectively. CR1 levels were normal in asthmatics undergoing long-term treatment with prednisone. In SLE patients, significant correlations were found between CR1 levels, C4 hemolytic titers, and levels of circulating immune complexes. In two out of four patients with SLE, CR1 levels increased significantly during remission, showing that the deficiency is, at least in part, reversible. The deficiency in CR1 could be genetically controlled or could represent an epiphenomenon caused by the interaction of the receptor with a ligand present in the circulation of patients.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Isaak, A., Gergely, P. Jr, Szekeres, Z., Prechl, J., Poor, G., Erdei, A., Gergely, J. (2008). Physiological up-regulation of inhibitory receptors Fc{gamma}RII and CR1 on memory B cells is lacking in SLE patients. Int Immunol 20: 185-192 [Abstract] [Full Text]
Craig, M. L., Waitumbi, J. N., Taylor, R. P. (2005). Processing of C3b-Opsonized Immune Complexes Bound to Non-Complement Receptor 1 (CR1) Sites on Red Cells: Phagocytosis, Transfer, and Associations with CR1. J. Immunol. 174: 3059-3066 [Abstract] [Full Text]
de Carvalho Lins, C E, Crott, L S P., Teixeira, J E, Barbosa, J E (2004). Reduced erythrocyte complement receptor type 1 in systemic lupus erythematosus is related to a disease activity index and not to the presence or severity of renal disease. Lupus 13: 517-521 [Abstract]
Zorzetto, M., Ferrarotti, I., Trisolini, R., Agli, L. L., Scabini, R., Novo, M., De Silvestri, A., Patelli, M., Martinetti, M., Cuccia, M., Poletti, V., Pozzi, E., Luisetti, M. (2003). Complement Receptor 1 Gene Polymorphisms Are Associated with Idiopathic Pulmonary Fibrosis. Am. J. Respir. Crit. Care Med. 168: 330-334 [Abstract] [Full Text]
Miyaike, J, Iwasaki, Y, Takahashi, A, Shimomura, H, Taniguchi, H, Koide, N, Matsuura, K, Ogura, T, Tobe, K, Tsuji, T (2002). Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases. Gut 51: 591-596 [Abstract] [Full Text]
Nielsen, C. H., Leslie, R. G. Q. (2002). Complement's participation in acquired immunity. J. Leukoc. Biol. 72: 249-261 [Abstract] [Full Text]
Iannuzzi, M. C., Maliarik, M., Rybicki, B. A. (2002). Nomination of a Candidate Susceptibility Gene in Sarcoidosis . The Complement Receptor 1 Gene. Am. J. Respir. Cell Mol. Bio. 27: 3-7 [Full Text]
Oudin, S., Libyh, M. T., Goossens, D., Dervillez, X., Philbert, F., Reveil, B., Bougy, F., Tabary, T., Rouger, P., Klatzmann, D., Cohen, J. H. M. (2000). A Soluble Recombinant Multimeric Anti-Rh(D) Single-Chain Fv/CR1 Molecule Restores the Immune Complex Binding Ability of CR1-Deficient Erythrocytes. J. Immunol. 164: 1505-1513 [Abstract] [Full Text]
Gonzalez, M. L., Waxman, F. J. (2000). Glomerular Deposition of Immune Complexes Made with IgG2a Monoclonal Antibodies. J. Immunol. 164: 1071-1077 [Abstract] [Full Text]
Lach-Trifilieff, E., Marfurt, J., Schwarz, S., Sadallah, S., Schifferli, J. A. (1999). Complement Receptor 1 (CD35) on Human Reticulocytes: Normal Expression in Systemic Lupus Erythematosus and HIV-Infected Patients. J. Immunol. 162: 7549-7554 [Abstract] [Full Text]
Schur, P.H. (1995). Review: Genetics of systemic lupus erythematosus. Lupus 4: 425-437
Griggs, R. C., Karpati, G. (1991). The Pathogenesis of Dermatomyositis. Arch Neurol 48: 21-22 [Abstract]
GALLIN, J. I., BUESCHER, E. S., SELIGMANN, B. E., NATH, J., GAITHER, T., KATZ, P. (1983). Recent Advances in Chronic Granulomatous Disease. ANN INTERN MED 99: 657-674 [Abstract]